scholarly journals Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infection

2012 ◽  
Vol 5 (3) ◽  
pp. 179-188 ◽  
Author(s):  
Paul Y. Kwo
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitor ◽  
Chronic Hepatitis C ◽  
Hepatitis C Infection ◽  
Ns3 Protease

scholarly journals Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient

Virology ◽  
2008 ◽  
Vol 370 (2) ◽  
pp. 237-245 ◽  
Author(s):  
Maria Cubero ◽  
Juan Ignacio Esteban ◽  
Teresa Otero ◽  
Silvia Sauleda ◽  
Marta Bes ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitor ◽  
Chronic Hepatitis C ◽  
Resistant Mutant ◽  
Naturally Occurring ◽  
Ns3 Protease

Pharmacokinetics of the NS3 Protease Inhibitor, Asunaprevir (ASV, BMS-650032), in Phase I Studies in Subjects With or Without Chronic Hepatitis C

2013 ◽  
Vol 2 (4) ◽  
pp. 316-327 ◽  
Author(s):  
Timothy Eley ◽  
Bing He ◽  
Shu-Pang Huang ◽  
Wenying Li ◽  
Claudio Pasquinelli ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Protease Inhibitor ◽  
Phase I ◽  
Chronic Hepatitis C ◽  
Phase I Studies ◽  
Ns3 Protease

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

2015 ◽  
Vol 53 (05) ◽  
Author(s):  
K Kozbial ◽  
S Beinhardt ◽  
C Freissmuth ◽  
A Stättermayer ◽  
R Stern ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Liver Fibrosis ◽  
Chronic Hepatitis C ◽  
Hepatitis C Infection
Sign in / Sign up

Export Citation Format

Share Document